European Medicines Agency (EMA) to Amsterdam
The European Medicines Agency is relocating from London to Amsterdam. Various Dutch government authorities are working together to make sure the move goes smoothly.
What is the European Medicines Agency (EMA)?
The European Medicines Agency (EMA) was set up in 1995. It is responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU.
EMA is leaving London because of the UK’s decision to leave the European Union (Brexit). On 20 November 2017, the decision was taken in the margins of the meeting of the Council of the European Union that EMA would relocate to Amsterdam in 2019.
Temporary and permanent premises for EMA
The European Medicines Agency (EMA) will move from London to Amsterdam before 30 March 2019. Until the completion of its new headquarters in the Zuidas business district in November 2019, the EMA will occupy temporary premises in the Spark Building, close to Amsterdam Sloterdijk station.
Visit the website of the Central Government Real Estate Agency for more impressions of the new EMA Zuidas building in Amsterdam.
Where are the buildings located?
Temporary premises for EMA (Spark Building)
Orlyplein 2, Amsterdam
Permanent premises for EMA
Domenico Scarlattilaan, Amsterdam
To ensure that the relocation goes as smoothly as possible, these government authorities are working in partnership:
- the Ministry of Health, Welfare and Sport
- the Ministry of Foreign Affairs
- the Ministry of Education, Culture and Science
- the Central Government Real Estate Agency
- the Municipality of Amsterdam
- the Zuidas business district of Amsterdam.
Facts and figures about EMA
- EMA had a budget of €324 million in 2016. About half of this was spent directly in the host country.
- EMA approves about 90 new medicines every year.
- Around 1.2 million adverse reactions to medicines are recorded in its database.
- EMA’s network includes 40 pharmaceutical authorities and almost 4,000 experts.
- EMA receives 36,000 visitors and holds 565 international meetings per year.
- EMA employs almost 900 staff at its current headquarters in Canary Wharf, London.
The European Medicines Agency (EMA) and the Netherlands agree on Seat Agreement
EMA and the Netherlands have finalized the text of a Seat Agreement which describes how the Agency, its bodies and its...
Briefing temporary and permanent building EMA
Briefing relocation staff EMA
Briefing relocation EMA
Letter from the Minister for Medical Care and Sport on the relocation of the European Medicines Agency
Letter to the House of Representatives on the relocation of the European Medicines Agency. The letter outlines the progress...
Speech Minister Bruno Bruins at press conference about relocation European Medicines Agency (EMA) from London to Amsterdam
Offer for EMA – Annex to the Dutch bid to host the European Medicines Agency
In this annex to the Dutch bid to host the European Medicines Agency, further information is provided on the temporary office...
Letter from Dutch authorities to European Commission about EMA
Letter from the minister for Medical Care and Sport to the European Commission about the Dutch bid for the European Medicines...
The Dutch bid for the European Medicines Agency
Kamerbrief over aanbieding bidbook European Medicines Agency
Minister Schippers (VWS) stuurt het bidbook European Medicines Agency aan de Tweede Kamer.